Eli Lilly's Weight Loss Pill Gains Global Approval

Eli Lilly's new weight-loss pill, Foundayo, recently gained approval for use in the U.K. This marks a big step for the drugmaker. Foundayo can now compete with other popular weight-loss treatments around the world.

Foundayo is a once-a-day pill. It helps people lose weight. This approval means more options for patients in the U.K. who struggle with obesity.

The market for weight-loss drugs is growing fast. Eli Lilly enters this global market. They will now go up against Novo Nordisk's drug, Wegovy. Wegovy is another well-known weight-loss treatment.

This approval shows Foundayo's potential. It offers a new choice for weight management. Patients around the world may soon access this treatment.

Source: CNBC